138 related articles for article (PubMed ID: 34180308)
21. Prediction of biochemical recurrence after radical prostatectomy with PI-RADS version 2 in prostate cancers: initial results.
Park SY; Oh YT; Jung DC; Cho NH; Choi YD; Rha KH; Hong SJ
Eur Radiol; 2016 Aug; 26(8):2502-9. PubMed ID: 26560721
[TBL] [Abstract][Full Text] [Related]
22. Patterns and predictors of early biochemical recurrence after radical prostatectomy and adjuvant radiation therapy in men with pT3N0 prostate cancer: implications for multimodal therapies.
Briganti A; Joniau S; Gandaglia G; Cozzarini C; Sun M; Tombal B; Haustermans K; Hinkelbein W; Shariat SF; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):960-7. PubMed ID: 24351411
[TBL] [Abstract][Full Text] [Related]
23. Identification of patients at risk for biochemical recurrence after radical prostatectomy with intra-operative frozen section.
Tully KH; Schulmeyer M; Hanske J; Reike MJ; Brock M; Moritz R; Jütte H; Tannapfel A; von Bodman C; Noldus J; Palisaar RJ; Roghmann F
BJU Int; 2021 Nov; 128(5):598-606. PubMed ID: 33961328
[TBL] [Abstract][Full Text] [Related]
24. Surface-enhanced Raman spectroscopy before radical prostatectomy predicts biochemical recurrence better than CAPRA-S.
Pan J; Shao X; Zhu Y; Dong B; Wang Y; Kang X; Chen N; Chen Z; Liu S; Xue W
Int J Nanomedicine; 2019; 14():431-440. PubMed ID: 30666105
[TBL] [Abstract][Full Text] [Related]
25. Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progression.
Schiffmann J; Salomon G; Tilki D; Budäus L; Karakiewicz PI; Leyh-Bannurah SR; Pompe RS; Haese A; Heinzer H; Huland H; Graefen M; Tennstedt P
Urol Oncol; 2017 May; 35(5):243-249. PubMed ID: 28161322
[TBL] [Abstract][Full Text] [Related]
26. Late biochemical recurrence after radical prostatectomy is associated with a slower rate of progression.
Chow K; Herrera P; Stuchbery R; Peters JS; Costello AJ; Hovens CM; Corcoran NM
BJU Int; 2019 Jun; 123(6):976-984. PubMed ID: 30248237
[TBL] [Abstract][Full Text] [Related]
27. Impact of Gleason pattern 5 including tertiary pattern 5 on outcomes of salvage treatment for biochemical recurrence in pT2-3N0M0 prostate cancer.
Taguchi S; Shiraishi K; Fukuhara H; Nakagawa K; Morikawa T; Naito A; Kakutani S; Takeshima Y; Miyazaki H; Nakagawa T; Fujimura T; Kume H; Homma Y
Int J Clin Oncol; 2016 Oct; 21(5):975-980. PubMed ID: 27098807
[TBL] [Abstract][Full Text] [Related]
28. Preoperative predictive factors and further risk stratification of biochemical recurrence in clinically localized high-risk prostate cancer.
Hamada R; Nakashima J; Ohori M; Ohno Y; Komori O; Yoshioka K; Tachibana M
Int J Clin Oncol; 2016 Jun; 21(3):595-600. PubMed ID: 26585896
[TBL] [Abstract][Full Text] [Related]
29. Improving the prediction of biochemical recurrence after radical prostatectomy with the addition of detailed pathology of the positive surgical margin and cribriform growth.
Remmers S; Hollemans E; Nieboer D; Luiting HB; van Leenders GJLH; Helleman J; Roobol MJ
Ann Diagn Pathol; 2022 Feb; 56():151842. PubMed ID: 34717190
[TBL] [Abstract][Full Text] [Related]
30. Body mass index is associated with higher Gleason score and biochemical recurrence risk following radical prostatectomy in Chinese men: a retrospective cohort study and meta-analysis.
Bai PD; Hu MB; Xu H; Zhu WH; Hu JM; Yang T; Jiang HW; Ding Q
World J Surg Oncol; 2015 Nov; 13():311. PubMed ID: 26542246
[TBL] [Abstract][Full Text] [Related]
31. Long-term cancer control outcomes in patients with biochemical recurrence and the impact of time from radical prostatectomy to biochemical recurrence.
Pompe RS; Gild P; Karakiewicz PI; Bock LP; Schlomm T; Steuber T; Graefen M; Huland H; Tian Z; Tilki D
Prostate; 2018 Jun; 78(9):676-681. PubMed ID: 29570821
[TBL] [Abstract][Full Text] [Related]
32. A novel serum biomarker quintet reveals added prognostic value when combined with standard clinical parameters in prostate cancer patients by predicting biochemical recurrence and adverse pathology.
Athanasiou A; Tennstedt P; Wittig A; Huber R; Straub O; Schiess R; Steuber T
PLoS One; 2021; 16(11):e0259093. PubMed ID: 34767586
[TBL] [Abstract][Full Text] [Related]
33. Race and prostate weight as independent predictors for biochemical recurrence after radical prostatectomy.
Schroeck FR; Sun L; Freedland SJ; Jayachandran J; Robertson CN; Moul JW
Prostate Cancer Prostatic Dis; 2008; 11(4):371-6. PubMed ID: 18427570
[TBL] [Abstract][Full Text] [Related]
34. Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database.
Mithal P; Howard LE; Aronson WJ; Kane CJ; Cooperberg MR; Terris MK; Amling CL; Freedland SJ
Int J Urol; 2015 Apr; 22(4):362-6. PubMed ID: 25728968
[TBL] [Abstract][Full Text] [Related]
35. Predictive Value of Preoperative Prostate Health Index and Serum Testosterone Testing for Biochemical Recurrence after Radical Prostatectomy for Non-Metastatic Prostate Cancer.
Zhang C; Zhang Y; Niu N; Fu G
Arch Esp Urol; 2023 Dec; 76(10):787-795. PubMed ID: 38186072
[TBL] [Abstract][Full Text] [Related]
36. Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy?
Boorjian SA; Bianco FJ; Scardino PT; Eastham JA
BJU Int; 2005 Oct; 96(6):773-6. PubMed ID: 16153197
[TBL] [Abstract][Full Text] [Related]
37. Machine learning algorithms can more efficiently predict biochemical recurrence after robot-assisted radical prostatectomy.
Ekşi M; Evren İ; Akkaş F; Arıkan Y; Özdemir O; Özlü DN; Ayten A; Sahin S; Tuğcu V; Taşçı AI
Prostate; 2021 Sep; 81(12):913-920. PubMed ID: 34224165
[TBL] [Abstract][Full Text] [Related]
38. Analysis of quality of life and late biochemical predictors for localized cancer recurrence following radical prostatectomy.
Friedersdorff F; Buckendahl L; Alt L; Maxeiner A; Hinz S; Bichmann A; Miller K; Magheli A; Busch J
World J Urol; 2020 Jun; 38(6):1501-1507. PubMed ID: 31463559
[TBL] [Abstract][Full Text] [Related]
39. The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence.
Karl A; Buchner A; Tympner C; Kirchner T; Ganswindt U; Belka C; Ganzer R; Burger M; Eder F; Hofstädter F; Schilling D; Sievert K; Stenzl A; Scharpf M; Fend F; Vom Dorp F; Rübben H; Schmid K; Porres-Knoblauch D; Heidenreich A; Hangarter B; Knüchel-Clarke R; Rogenhofer M; Wullich B; Hartmann A; Comploj E; Pycha A; Hanspeter E; Pehrke D; Sauter G; Graefen M; Stief C; Haese A
World J Urol; 2015 Jul; 33(7):973-9. PubMed ID: 25682109
[TBL] [Abstract][Full Text] [Related]
40. Tumor volume improves the long-term prediction of biochemical recurrence-free survival after radical prostatectomy for localized prostate cancer with positive surgical margins.
Meyer CP; Hansen J; Boehm K; Tilki D; Abdollah F; Trinh QD; Fisch M; Sauter G; Graefen M; Huland H; Chun FK; Ahyai SA
World J Urol; 2017 Feb; 35(2):199-206. PubMed ID: 27260503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
